Hyperscale Data unit to buy up to 143 AGIBOT robots for $13.4M, deploy in Michigan

Hyperscale Data, Inc.

Omnipresent Robotics signed Appendix to Partner Agreement with AGIBOT to acquire up to 143 intelligent robots.
Purchase price up to ~$13.4M via purchase orders; Omnipresent authorized to resell under its own brand.
~100,000 sq ft of existing 617,000 sq ft Michigan data center allocated to robotics, teleoperation bays, and embodied AI training.
Deployment supports domestic VLA data processing, robot dataset generation, and Michigan workforce expansion in teleoperation, data labeling, engineering.
Agreement supplements Partner Agreement dated April 15, 2026; no assurance on timing or commercialization.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Hyperscale Data, Inc. entered into Appendix with AGIBOT PTE. LTD. valued at up to approximately $13.4 million (effective 2026-05-09).

Action: entry
Counterparty: AGIBOT PTE. LTD.
Value: up to approximately $13.4 million
Effective: 2026-05-09

Exact text from the filing

On May 9, 2026, Hyperscale Data, Inc., a Delaware corporation (the “ Company ”), through its wholly-owned subsidiary, Omnipresent Robotics LLC, a Nevada limited liability company (the “ Omnipresent ”), entered into a definitive Appendix (the “ Appendix ”) with AGIBOT PTE. LTD., a Singaporean company (“ AGIBOT ”), which supplements that certain Partner Agreement dated April 15, 2026 (the “ Partner Agreement ”) entered into by and between Omnipresent and AGIBOT.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Hyperscale Data, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-26-005936

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.